Stock Events

Stock Events

SAB Biotherapeutics (SABSW) Q4 2024 Earnings

Nov 6Confirmed

Sep 2021

Q2 2024

Q3 2024

Q4 2024

-1.15

-0.76

-0.38

0

Details

Expected EPS

-1.106

Actual EPS

-1.12

Surprise EPS

-0.01

Surprise Percent

-1.27%

Description

⁨SAB Biotherapeutics⁩ (⁦SABSW⁩) has reported earnings of ⁦-1.12⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.